SCHEMBL3971491

SCHEMBL3971491

C[Si](C)(C)c1ccc([Si](C)(C)C)c(C=O)c1O

nearest known ligand 0.38

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PADI4 Q9UM07 1/20 0.38
ERN1 O75460 13/20 0.37
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 1/20 0.34
AOX1 Q06278 1/20 0.34
TRIM24 O15164 1/20 0.33
TRIM33 Q9UPN9 1/20 0.33
CYP3A4 P08684 1/20 0.32
MAPT P10636 1/20 0.32
ALB P02768 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4301326 0.75 ALDH1A1 (0.32) ALDH1A1
SCHEMBL1092768 0.75 ERN1 (0.41) PADI4ERN1MEN1ALDH1A1KMT2A
SCHEMBL2813925 0.75 ALDH1A1 (0.42) PADI4ERN1MEN1ALDH1A1LMNA
SCHEMBL3966498 0.71 ERN1 (0.55) ERN1MEN1ALDH1A1LMNAKMT2A
SCHEMBL5697208 0.69 ERN1 (0.39) ERN1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL30238132 0.68 MEN1 (0.42) ERN1MEN1ALDH1A1LMNAHPGD
SCHEMBL8519885 0.68 MEN1 (0.42) ERN1MEN1ALDH1A1LMNAHPGD
SCHEMBL7736581 0.67 KMT2A (0.61) KDM4EMEN1ALDH1A1LMNAHPGD
SCHEMBL13100027 0.67 ERN1 (0.38) ERN1MEN1ALDH1A1HPGDKMT2A
SCHEMBL8743110 0.67 MEN1 (0.31) MEN1ALDH1A1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1992630-B1 Covalently fixed non-metallocenes, method for the production thereof and their use for polymerizing olefins TICONA GMBH (DE) 2012-10-31 EP disclosed
EP-1480987-B1 COVALENTLY FIXED NON-METALLOCENES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR POLYMERIZING OLEFINS CELANESE HOLDING GMBH (DE) 2009-07-29 EP disclosed
EP-1992630-A1 Covalently fixed non-metallocenes, method for the production thereof and their use for polymerizing olefins Celanese Holding GmbH (DE) 2008-11-19 EP disclosed
US-7157398-B2 Covalently fixed nonmetallocenes, process for preparing them and their use for the polymerization of olefins CELANESE VENTURES GMBH (DE) 2007-01-02 US disclosed
US-20050148461-A1 Covalently fixed nonmetallocenes, process for preparing them and their use for the polymerization of olefins CELANESE VENTURES GMBH (DE) 2005-07-07 US disclosed
US-6872843-B2 Non-metallocene compounds, method for the production thereof and use of the same for the polymerization of olefins BASELL POLYOLEFINE GMBH (DE) 2005-03-29 US disclosed
US-20040023940-A1 Non-metallocene compounds, method for the production thereof and use of the same for the polymerisation of olefins EQUISTAR CHEMICALS, LP 2004-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040023940-A1 Non-metallocene compounds, method for the production thereof and use of the same for the polymerisation of olefins SOAT2, NOTUM, SOAT1 PADI4 1354/4885ERN1 2212/4885KDM4E 3003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.